Publications

​​Research Articles 

 

View full list of peer-reviewed publications in Google Scholar

​

​​​

• Portfolio Optimization for R&D Projects: A Real Options Dynamic Programming Approach*​

       Leonid Kogan, Andrew W. Lo, Qingyang Xu, and Ruixun Zhang

       Under Review​​

• 17th Annual Conference on Advances in the Analysis of Hedge Fund Strategies

​​

• Estimating Correlations Between Clinical Trial Outcomes Using Generalized Estimating Equations

       Yuehao Dai, Andrew W. Lo, Manish Singh, Qingyang Xu, and Ruixun Zhang

       Oxford Bulletin of Economics and Statistics (2025)

​

• Use of Bayesian Decision Analysis in the Design of Patient-centered Clinical Trials for Kidney Failure Devices

       Zied Ben Chaouch, Qingyang Xu, Shomesh E. Chaudhuri, ..., and Andrew W. Lo

       Computers in Biology and Medicine (2025) 198, 111150

​

• A Father’s Crusade in Rare Disease Drug Development: A Case Study of Elpida Therapeutics and Melpida

       Deanna Portero, Qingyang Xu, Aaliya Hussain, and Andrew W. Lo

       Orphanet Journal of Rare Diseases (2025) 20(1), 363

​

• Predicting Clinical Trial Duration via Statistical and Machine Learning Models

       Joonhyuk Cho, Qingyang Xu, Chi Heem Wong, and Andrew W. Lo

       Contemporary Clinical Trials Communications (2025) 101473

​​

• Incorporating Patient Preferences and Burden-of-disease in Evaluating ALS Drug Candidate AMX0035: A Bayesian Decision Analysis Perspective

       Qingyang Xu, Joonhyuk Cho, Zied Ben Chaouch, and Andrew W. Lo

       Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2023) 24(3-4), 281-288 

​​

• Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery

       Joseph Barberio, Jacob Becraft, Zied Ben Chaouch, Dimitris Bertsimas, Tasuku Kitada,

       Michael L. Li, Andrew W. Lo, Kevin Shi, and Qingyang Xu

  Entrepreneurship and Innovation Policy and the Economy (2023) 2(1), 9–39

​

• Identifying and Mitigating Potential Biases in Predicting Drug Approvals

       Qingyang Xu, Elaheh Ahmadi, Alexander Amini, Daniela Rus, and Andrew W. Lo

       Drug Safety (2022) 45: 521–533

​

• Real-Time Extended Psychophysiological Analysis of Financial Risk Processing

       Manish Singh, Qingyang Xu, Sarah J. Wang, Tinah Hong, Mohammad M. Ghassemi, and

       Andrew W. Lo

       PLOS ONE (2022) 17(7): e0269752

​

• Accelerating Glioblastoma Therapeutics via Venture Philanthropy

       Kien Wei Siah, Qingyang Xu, Kirk Tanner, Olga Futer, John J. Frishkopf, and Andrew W. Lo

       Drug Discovery Today (2021) 26(7): 1744–1749

​

• Two-Stage Framework for Seasonal Time Series Forecasting

​       Qingyang Xu, Qingsong Wen, Liang Sun

       ICASSP (2021)

​​

• Bayesian Adaptive Clinical Trials for Anti‐Infective Therapeutics during Epidemic Outbreaks

       Shomesh Chaudhuri, Andrew W. Lo, Danying Xiao, and Qingyang Xu

       Harvard Data Science Review (2020) Special Issue 1

​

• Visualizing Probabilistic Models in Minkowski Space with Intensive Symmetrized Kullback-Leibler Embedding

       Han Kheng Teoh, Katherine Quinn, Jaron Kent-Dobias, Colin Clement, Qingyang Xu, and

       James Sethna

       Physical Review Research (2020) 2, 03321

​

• Fair and Responsible Drug Pricing: A Case Study of Radius Health and abaloparatide

       Qingyang Xu and Andrew W. Lo

       Journal of Investment Management (2020) 18(1): 90–98

​​​​

​​

​​

​Book

​​

• The Algorithmic World《无处不在的算法》

       Qingyang Xu

       Shanghai Educational Publishing House (2025)

        ISBN 978-7-5720-3626-2​

​​​

​

​​

Theses  

​

• Financial and Analytic Innovations for Therapeutic Development

       Ph.D. Thesis, MIT (2022)

​

• Quantum Tunneling and Spontaneous Baryogenesis in the Relaxion Model

       Undergraduate Honors Thesis, Stanford (2017)

​

​

Patent​

​​​

• Next gen ETA machine learning (ML) system. US Patent App. 19/067,414